These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 29641996)

  • 1. Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism.
    Schuijers J; Manteiga JC; Weintraub AS; Day DS; Zamudio AV; Hnisz D; Lee TI; Young RA
    Cell Rep; 2018 Apr; 23(2):349-360. PubMed ID: 29641996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.
    Ottema S; Mulet-Lazaro R; Erpelinck-Verschueren C; van Herk S; Havermans M; Arricibita Varea A; Vermeulen M; Beverloo HB; Gröschel S; Haferlach T; Haferlach C; J Wouters B; Bindels E; Smeenk L; Delwel R
    Nat Commun; 2021 Sep; 12(1):5679. PubMed ID: 34584081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute depletion of CTCF directly affects MYC regulation through loss of enhancer-promoter looping.
    Hyle J; Zhang Y; Wright S; Xu B; Shao Y; Easton J; Tian L; Feng R; Xu P; Li C
    Nucleic Acids Res; 2019 Jul; 47(13):6699-6713. PubMed ID: 31127282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 represses c-MYC transcription by altering the co-activator landscape of the c-MYC super-enhancer and promoter regions.
    Ormsbee Golden BD; Gonzalez DV; Yochum GS; Coulter DW; Rizzino A
    J Biol Chem; 2024 Sep; 300(9):107642. PubMed ID: 39122009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
    Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
    Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
    [No Abstract]   [Full Text] [Related]  

  • 6. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.
    Xiang JF; Yin QF; Chen T; Zhang Y; Zhang XO; Wu Z; Zhang S; Wang HB; Ge J; Lu X; Yang L; Chen LL
    Cell Res; 2014 May; 24(5):513-31. PubMed ID: 24662484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
    Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
    Kang J; Kim YW; Park S; Kang Y; Kim A
    FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural and functional roles of CTCF in the regulation of cell type-specific and human disease-associated super-enhancers.
    Shin HY
    Genes Genomics; 2019 Mar; 41(3):257-265. PubMed ID: 30456521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BET inhibition disrupts transcription but retains enhancer-promoter contact.
    Crump NT; Ballabio E; Godfrey L; Thorne R; Repapi E; Kerry J; Tapia M; Hua P; Lagerholm C; Filippakopoulos P; Davies JOJ; Milne TA
    Nat Commun; 2021 Jan; 12(1):223. PubMed ID: 33431820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canonical WNT signaling-dependent gating of MYC requires a noncanonical CTCF function at a distal binding site.
    Chachoua I; Tzelepis I; Dai H; Lim JP; Lewandowska-Ronnegren A; Casagrande FB; Wu S; Vestlund J; Mallet de Lima CD; Bhartiya D; Scholz BA; Martino M; Mehmood R; Göndör A
    Nat Commun; 2022 Jan; 13(1):204. PubMed ID: 35017527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.
    Ahmed M; Soares F; Xia JH; Yang Y; Li J; Guo H; Su P; Tian Y; Lee HJ; Wang M; Akhtar N; Houlahan KE; Bosch A; Zhou S; Mazrooei P; Hua JT; Chen S; Petricca J; Zeng Y; Davies A; Fraser M; Quigley DA; Feng FY; Boutros PC; Lupien M; Zoubeidi A; Wang L; Walsh MJ; Wang T; Ren S; Wei GH; He HH
    Nat Commun; 2021 Mar; 12(1):1781. PubMed ID: 33741908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer release and retargeting activates disease-susceptibility genes.
    Oh S; Shao J; Mitra J; Xiong F; D'Antonio M; Wang R; Garcia-Bassets I; Ma Q; Zhu X; Lee JH; Nair SJ; Yang F; Ohgi K; Frazer KA; Zhang ZD; Li W; Rosenfeld MG
    Nature; 2021 Jul; 595(7869):735-740. PubMed ID: 34040254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR‑29 promoter and enhancer methylation identified by pyrosequencing in Burkitt lymhoma cells: Interplay between MYC and miR‑29 regulation.
    Mazzoccoli L; Robaina MC; Bacchi CE; Soares Lima SC; Klumb CE
    Oncol Rep; 2019 Aug; 42(2):775-784. PubMed ID: 31173259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.
    Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH
    Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.
    Shi J; Whyte WA; Zepeda-Mendoza CJ; Milazzo JP; Shen C; Roe JS; Minder JL; Mercan F; Wang E; Eckersley-Maslin MA; Campbell AE; Kawaoka S; Shareef S; Zhu Z; Kendall J; Muhar M; Haslinger C; Yu M; Roeder RG; Wigler MH; Blobel GA; Zuber J; Spector DL; Young RA; Vakoc CR
    Genes Dev; 2013 Dec; 27(24):2648-62. PubMed ID: 24285714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional assessment of CTCF sites at cytokine-sensing mammary enhancers using CRISPR/Cas9 gene editing in mice.
    Lee HK; Willi M; Wang C; Yang CM; Smith HE; Liu C; Hennighausen L
    Nucleic Acids Res; 2017 May; 45(8):4606-4618. PubMed ID: 28334928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression.
    Mortenson KL; Dawes C; Wilson ER; Patchen NE; Johnson HE; Gertz J; Bailey SD; Liu Y; Varley KE; Zhang X
    Nat Commun; 2024 Jul; 15(1):6130. PubMed ID: 39033128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTCF-Mediated Enhancer-Promoter Interaction Is a Critical Regulator of Cell-to-Cell Variation of Gene Expression.
    Ren G; Jin W; Cui K; Rodrigez J; Hu G; Zhang Z; Larson DR; Zhao K
    Mol Cell; 2017 Sep; 67(6):1049-1058.e6. PubMed ID: 28938092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
    Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
    Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.